PT  - JOURNAL ARTICLE
AU  - Wen, Ying
AU  - Wei, Lan
AU  - Li, Yuan
AU  - Tang, Xiujuan
AU  - Feng, Shuo
AU  - Leung, Kathy
AU  - Wu, Xiaoliang
AU  - Pan, Xiong-Fei
AU  - Chen, Cong
AU  - Xia, Junjie
AU  - Zou, Xuan
AU  - Feng, Tiejian
AU  - Mei, Shujiang
TI  - Epidemiological and Clinical Characteristics of Coronavirus Disease 2019 in Shenzhen, the Largest Migrant City of China
AID  - 10.1101/2020.03.22.20035246
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.22.20035246
4099  - http://medrxiv.org/content/early/2020/03/23/2020.03.22.20035246.short
4100  - http://medrxiv.org/content/early/2020/03/23/2020.03.22.20035246.full
AB  - We conducted a retrospective study among 417 confirmed COVID-19 cases from Jan 1 to Feb 28, 2020 in Shenzhen, the largest migrant city of China, to identify the epidemiological and clinical features in settings of high population mobility. We estimated the median incubation time to be 5.0 days. 342 (82.0%) cases were imported, 161 (38.6%) cases were identified by surveillance, and 247 (59.2%) cases were reported from cluster events. The main symptoms on admission were fever and dry cough. Most patients (91.4%) had mild or moderate illnesses. Age of 50 years or older, breathing problems, diarrhea, and longer time between the first medical visit and admission were associated with higher level of clinical severity. Surveillance-identified cases were much less likely to progress to severe illness. Although the COVID-19 epidemic has been contained in Shenzhen, close monitoring and risk assessments are imperative for prevention and control of COVID-19 in future.Article Summary Line We characterized epidemiological and clinical features of a large population-based sample of COVID-19 cases in the largest migrant city of China, and our findings could provide knowledge of SARS-CoV-2 transmission in the context of comprehensive containment and mitigation efforts in similar settings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data in this manuscript are not available now.